SCHEMBL29721868

SCHEMBL29721868

CC(C)[Si](C(C)C)(C(C)C)n1ccc2c(Cl)c(F)c(Cl)nc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23147854 1.00 — —
SCHEMBL29722077 0.89 — —
SCHEMBL23147851 0.89 — —
SCHEMBL23148023 0.88 HTR2A (0.32) —
SCHEMBL23148019 0.82 — —
SCHEMBL29431048 0.76 HTR2A (0.35) —
SCHEMBL29722426 0.76 — —
SCHEMBL23148094 0.76 — —
SCHEMBL2105174 0.76 HTR2A (0.35) —
SCHEMBL1468966 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4034108-A1 AZAINDOLE CARBOXAMIDE COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS The Global Alliance for TB Drug Development, Inc. (US) 2022-08-03 — — EP disclosed
CN-114746090-A Azaindole carboxamide compounds for the treatment of mycobacterial infections 结核病药物开发全球联盟公司 2022-07-12 — — CN disclosed
Send feedback